The 9-day notice: how a compounding wind-down works in the United Arab Emirates
The document is four pages. Three of them are about dates.
Recent work
120 piecesThe dose that got you here and the dose that keeps you here
Dose reduction is not withdrawal, and the trials that tested withdrawal cannot be read as testing it.
The 26-day notice: how a compounding wind-down works in the United Kingdom
The document is four pages. Three of them are about dates.
A shortage listing ends. 16 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The relabeller trading as Vantris Bio enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
The shortage years, and what they taught about interruption
The trials studied planned withdrawal. Almost nobody stops that way.
The 8-day notice: how a compounding wind-down works in Norway
The document is four pages. Three of them are about dates.
The 8-day notice: how a compounding wind-down works in South Africa
The document is four pages. Three of them are about dates.
Calder Vale Peptides of Skipton enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Continued treatment against continued placebo: the comparison that settled it
The evidence on stopping is better than the evidence on almost anything else in this field, because somebody deliberately randomised it.
The 7-day notice: how a compounding wind-down works in Nigeria
The document is four pages. Three of them are about dates.
Inspectors cite the online reseller trading as Adamant Research Supply over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The 24-day notice: how a compounding wind-down works in the United Kingdom
The document is four pages. Three of them are about dates.
The supply gap as a clinical event
Cost is the modal reason for discontinuation in every dataset we have seen, and it is absent from the clinical literature.
A shortage listing ends. 8 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
A shortage listing ends. 13 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The 26-day notice: how a compounding wind-down works in the United Kingdom
The document is four pages. Three of them are about dates.
A shortage listing ends. 10 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
A shortage listing ends. 3 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
Side effects, cost, supply, target: four reasons with four trajectories
The trials studied planned withdrawal. Almost nobody stops that way.